Assembly Biosciences Management
Management criteria checks 2/4
Assembly Biosciences' CEO is Jason Okazaki, appointed in Aug 2022, has a tenure of 1.67 years. total yearly compensation is $1.80M, comprised of 30.8% salary and 69.2% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $98.92K. The average tenure of the management team and the board of directors is 3.4 years and 4.3 years respectively.
Key information
Jason Okazaki
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 30.8% |
| CEO tenure | 1.7yrs |
| CEO ownership | 0.1% |
| Management average tenure | 3.4yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
Here's Why Assembly Biosciences (NASDAQ:ASMB) Must Use Its Cash Wisely
Aug 17
Will Assembly Biosciences (NASDAQ:ASMB) Spend Its Cash Wisely?
Feb 27We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate
Nov 09Jason Okazaki to succeed John McHutchison as Assembly Biosciences CEO at year-end
Oct 05Assembly Biosciences to discontinue development of inhibitor vebicorvir, cut workforce
Jul 20We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate
Jun 08We're A Little Worried About Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate
Jan 11We're Keeping An Eye On Assembly Biosciences' (NASDAQ:ASMB) Cash Burn Rate
Sep 03Assembly Biosciences announces resignation of CFO
Jun 02Time To Worry? Analysts Just Downgraded Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Outlook
Mar 24Assembly Biosciences' (NASDAQ:ASMB) Shareholders Are Down 86% On Their Shares
Feb 05We're Hopeful That Assembly Biosciences (NASDAQ:ASMB) Will Use Its Cash Wisely
Dec 14
Assembly Bio inks deal with Door Pharmaceuticals to develop HBV core protein modulators
Nov 16Assembly Biosciences EPS beats by $0.69, beats on revenue
Nov 05CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$61m |
| Sep 30 2023 | n/a | n/a | -US$73m |
| Jun 30 2023 | n/a | n/a | -US$81m |
| Mar 31 2023 | n/a | n/a | -US$89m |
| Dec 31 2022 | US$2m | US$555k | -US$93m |
| Sep 30 2022 | n/a | n/a | -US$131m |
| Jun 30 2022 | n/a | n/a | -US$127m |
| Mar 31 2022 | n/a | n/a | -US$126m |
| Dec 31 2021 | US$1m | US$533k | -US$130m |
| Sep 30 2021 | n/a | n/a | -US$109m |
| Jun 30 2021 | n/a | n/a | -US$94m |
| Mar 31 2021 | n/a | n/a | -US$63m |
| Dec 31 2020 | US$4m | US$394k | -US$62m |
Compensation vs Market: Jason's total compensation ($USD1.80M) is above average for companies of similar size in the US market ($USD681.24K).
Compensation vs Earnings: Jason's compensation has increased whilst the company is unprofitable.
CEO
Jason Okazaki (47 yo)
1.7yrs
Tenure
US$1,801,214
Compensation
Mr. Jason A. Okazaki serves as Chief Executive Officer and Director at Assembly Biosciences, Inc. since January 01, 2023. He served as Chief Operating Officer of Assembly Biosciences, Inc. since August 1,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.7yrs | US$1.80m | 0.14% $ 102.1k | |
| Chief Scientific Officer | 3.3yrs | US$1.41m | 0.11% $ 78.0k | |
| Co-Founder and Clinical & Scientific Advisor | 9.8yrs | US$1.50m | no data | |
| Co-Founder | no data | no data | no data | |
| Executive Director of Accounting & Treasury | no data | no data | 0.028% $ 20.7k | |
| Senior Vice President of Investor Relations | no data | no data | no data | |
| Chief Human Resources Officer | 6.4yrs | no data | no data | |
| Chief Manufacturing Officer | 3.4yrs | no data | 0.092% $ 67.1k | |
| Chief Medical Officer | less than a year | no data | no data | |
| Executive Officer | 6yrs | US$652.02k | no data | |
| Investor Relations Consultant | no data | no data | no data |
3.4yrs
Average Tenure
51yo
Average Age
Experienced Management: ASMB's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 1.3yrs | US$1.80m | 0.14% $ 102.1k | |
| Co-Founder | 9.8yrs | no data | no data | |
| Independent Director | 12.3yrs | US$90.29k | 0.012% $ 8.9k | |
| Independent Non-Executive Chairman | 9.8yrs | US$132.79k | 0.027% $ 19.4k | |
| Director | 4.7yrs | US$1.76m | 0.22% $ 157.2k | |
| Independent Director | 6.3yrs | US$82.16k | 0% $ 0 | |
| Independent Director | 3.5yrs | US$79.66k | 0.084% $ 61.1k | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Board: ASMB's board of directors are considered experienced (4.3 years average tenure).